Seasoned Pharma Executive Julie Brown to Join Diageo's board

Julie Brown, the Chief Financial Officer and Executive Director of drugs giant GSK has been appointed as the non-executive director for Guinness and Smirnoff vodka maker Diageo. Her appointment will be effective from August 5.

Julie was appointed as the Chief Financial Officer and Executive Director of GSK in May 2023. Before this she was working for fashion brand Burberry Group as finance chief.

Julie will succeed Alan Stewart as chair of the audit committee at Diego. Alan will be retiring from the board immediately before Diego’s AGM in September.

Julie is a seasoned pharmaceuticals industry executive. She has previously held positions at Smith & Nephew and AstraZeneca.

Speaking about Julie’s new role, Diageo chairman Javier Ferrán said, “Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries.”

He further said, “She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world.”

Speaking about Alan’s tenure at Diego, group chairman noted, “Alan has served Diageo with great distinction during this period, and we have benefitted greatly from his expertise and strategic input. We wish him the very best for the future."